Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Abakan Appoints David Charbonneau to Board of Directors

Abstract:
Abakan Inc. (OTCQB ABKI) ("Abakan") today announced the appointment of David G. Charbonneau as an independent member of the Board of Directors. He is expected to serve as the Head of Abakan's Audit Committee and as a member of the recently formed Compensation, Nominating and Ethics Committees.

Abakan Appoints David Charbonneau to Board of Directors

Miami, FL | Posted on June 18th, 2012

Mr. Charbonneau has over 25 years of experience providing accounting and management expertise to a range of different industries. David earned a Bachelor of Science in Business Administration from Ohio State University with a major in Accounting. He is a Certified Public Accountant in Ohio, inactive. Mr. Charbonneau started his accounting career as an auditor for Arthur Anderson & Co in Cleveland. His experience includes 5 years as Chief Financial Officer for Diamond Engineered Space Inc. Diamond was a national commercial modular builder and a subsidiary of a UK publically traded company. The company was sold to GE Capital in 1993. Afterward, Mr. Charbonneau became Chief Financial Officer and Director for Waco International Corporation until 1998. Waco was a scaffolding manufacturer and construction rental equipment company with multiple US locations, 600 employees and over $75 million in revenue. The company was owned by an Australian public company. He was instrumental in the development and implementation of a strategic plan to transition it from a distressed company into a growing and profitable entity.

David is an Associate Director for SS&G Parkland, in Cleveland, Ohio, a business consulting group. His concentration is on strategic planning, performance improvements and financial institutional relationships. Mr. Charbonneau is also the founder of CFO Consultants, Inc. He advises clients on strategic planning, budget preparation, sales and margin enhancement, overhead cost management, accounting and financial institution relationships.

Mr. Charbonneau stated that he is "looking forward to this excellent opportunity to serve on the Board of Directors as an independent voice in Abakan's journey forward."

Abakan's CEO, Robert Miller stated that: "we are pleased to welcome an individual of David's caliber to the Board. Our plans for growth over the next 3 years dictate that we need someone like David to help ensure that the various corporate governance protocols, incumbent on growing public companies, are vigorously followed."

The appointment of Mr. Charbonneau coincides with the resignation of Mr. Buschor as a member of Abakan's Board of Directors. Abakan thanks Mr. Buschor for his service on the Board of Directors and looks forward to continuing to work with Mr. Buschor in his capacity as VP of Marketing.

####

About Abakan Inc.
Abakan, Inc. is a publicly listed company that provides critical financial, management and intellectual support to innovative companies and technologies for realizing their true market potential. Abakan invests in companies that have developed transformational technologies on the cusp of commercialization. Abakan is the largest shareholder in MesoCoat and Powdermet, each of which is a nanotechnology material science company involved in technology development and commercialization. MesoCoat is focused on metal asset protection and life extension by providing advanced wear and corrosion solutions, while Powdermet is focused on metal formulations as well as advanced energy management solutions. MesoCoat was recently recognized by Forbes as one of ‘The Most Promising American Companies’ and was the highest ranked material science and nanotechnology company. MesoCoat is also the recipient of four prestigious R&D 100 awards, a Technology Innovation Program Award (TIP) for 100 year life coatings by the National Institute of Standards and Technology (NIST), two NorTech Innovation Awards for breakthrough materials and surface engineering solutions, and several other federal and state grants and awards. Powdermet is a nationally recognized nanotechnology and advanced materials research and development organization that has won approximately 100 federal and state awards, along with being a recipient of several technology innovation awards like R&D 100 and NorTech Innovation Award.

Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward looking statements involve a number of risks and uncertainties including technological obsolescence, market acceptance of future products, competitive market conditions, and the sufficiency of capital resources. The actual results Abakan may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Abakan encourages the public to read the information provided here in conjunction with its most recent filings on Form 10-K and Form 10-Q. Abakan’s public filings may be viewed at www.sec.gov.

For more information, please click here

Contacts:
Abakan Inc.
Robert Miller, +1-786-206-5368
Chief Executive Officer

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Investments/IPO's/Splits

Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015

Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015

Announcements

New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Nexeon Board Changes Announced January 29th, 2015

Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015

SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015

Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE